comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 00:45:54 - browse：59

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： FDA approves Eli Lilly ulcerative colitis treatment Omvoh

WSS

Maker of FluMist seeks to allow at

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

In same hospitals, Black patients receive fewer opioids than white patients

FDA panel issues narrow recommendation for Covid vaccine booster doses

hotspot

comprehensive

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Biden's order seeks to regulate AI risk without stifling innovation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Medicare proposal to cover medical devices draws a mixed reaction

Police still searching for prisoner who escaped from NYC hospital

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Supreme Court strikes down use of affirmative action

American woman, child freed after being kidnapped in Haiti last month

focus

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Man killed during FBI raid in connection with threats against Biden, other officials

First Opinion Podcast: How to protect health care in times of war

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

NIH trials fail to test meaningful long Covid therapies, experts say

entertainment

focus

focus

explore